non-small-cell lung carcinoma - Globe Thesis

Keyword [non-small-cell lung carcinoma] Result: 121 - 140 \| Page: 7 of 7
121.	The Systematic Review Of Traditional Chinese Medicine Combined With EGFR-TKIs In The Treatment Of Middle To Late Stage Non-small-cell Lung Carcinoma With EGFR Mutations
122.	JQ1 Downregulates Met Expression And Inhibits The Growth Of Non-small Cell Lung Carcinoma Cells
123.	JQ1 Upregulates FoxO1 Expression To Inhibit The Growth Of Non-small Cell Lung Carcinoma Cells
124.	Relationship Between Serum Tumor Abnormal Protein And Chemotherapy Effect In Patients With Non-small-cell Lung Carcinoma
125.	Clinical Observation Of Liujun Erchen Decoction Combined With AP Regimen In The Treatment Of Advanced Non-small Cell Lung Cancer
126.	Clinical outcomes of patients with non-small cell lung carcinoma: a retrospective study
127.	Automated Detection and Differential Diagnosis of Non Small Cell Lung Carcinoma Cell Types Using Label-Flee Molecular Vibrational Imagin
128.	The Interaction Of APE1 And Its Related Proteins In Radiotherapy Of Human Cancer
129.	The Effect Of EGFR Gene Mutation Status On The Clinical Outcomes Of Patients With Non-small Cell Lung Cancer
130.	The Function And The Effect Significance Of PD-L1 In Mediating Cancer Cell Metastasis And Immno-escape From NK Cell Immunology In Non-small Cell Lung Carcinoma
131.	Clinical Outcomes And Optimal Treatment Strategy Of Epidermal Growth Factor Receptor Gene Mutated Locally Advanced Non-Small Cell Lung Cancer
132.	Endogenous Thrombopoietin Promotes Non-small Cell Lung Carcinoma Cell Proliferation And Migration By Regulating EGFR Signaling
133.	Analysis Of Differences In Immune Microenvironment Between Patients With EGFR Mutation And Wild-type NSCLC
134.	Cold Plasma Irradiation Regulates Inflammation And Oxidative Stress In Human Bronchial Epithelial Cells And Human Non-small Cell Lung Carcinoma
135.	The Investigation On Biological Effect Of Protamine 1in Non-small-cell Lung Carcinoma
136.	Exploring The Value Of B7-H5 As A Molecular Marker For Prognosis Of NSCLC
137.	A Study On The Effect Of Anlotinib On Lung Carcinoma Cell Line After EGFR-TKI Resistance
138.	The Role And Mechanism Of NLE1 In The Tumorigenesis And Development Of Non-small Cell Lung Carcinoma
139.	Application Of Systemic Immune Inflammation Index/Albumin Ratio In Prognostic Evaluation Of Surgable Non-small Cell Lung Carcinoma
140.	Plasma LncRNA FEZF1-AS1 As A Potential Biomarker For Diagnosis Of Non-small-cell Lung Carcinoma
<<First <Prev Next> Last>> Jump to